Eyesight Ophthalmic Services Pllc - Medicare in Portsmouth, NH

Eyesight Ophthalmic Services Pllc is a medicare enrolled "Ophthalmology" provider in Portsmouth, New Hampshire. Their current practice location is 155 Borthwick Ave, Suite 200 East, Portsmouth, New Hampshire. You can reach out to their office (for appointments etc.) via phone at (603) 436-1773.

Eyesight Ophthalmic Services Pllc is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Eyesight Ophthalmic Services Pllc is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1073736310.

Contact Information

Eyesight Ophthalmic Services Pllc
155 Borthwick Ave, Suite 200 East,
Portsmouth, NH 03801-7156
(603) 436-1773
(603) 433-6244



Healthcare Provider's Profile

Full NameEyesight Ophthalmic Services Pllc
TypeFacility
SpecialityOphthalmology
Location155 Borthwick Ave, Portsmouth, New Hampshire
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1073736310
  • Provider Enumeration Date: 04/11/2007
  • Last Update Date: 11/09/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 3971588609
  • Enrollment ID: O20080422000531

Medical Identifiers

Medical identifiers for Eyesight Ophthalmic Services Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1073736310NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist (* (Not Available))Secondary
174400000XSpecialist (* (Not Available))Secondary
207W00000XOphthalmology (* (Not Available))Primary
208600000XSurgery (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Eyesight Ophthalmic Services Pllc acts as a billing entity for following providers:
Provider NameChristopher James Turner
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1194728113
PECOS PAC ID: 6103815345
Enrollment ID: I20040610000463

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameLauren K Mcloughlin
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1790788719
PECOS PAC ID: 2860396652
Enrollment ID: I20050218000151

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameJanet S Rand
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1588667562
PECOS PAC ID: 3173576410
Enrollment ID: I20050225000600

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameNewton Timothy Peters
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1407859556
PECOS PAC ID: 5092739599
Enrollment ID: I20060124000364

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameMarsha Cheung Kavanagh
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1467403659
PECOS PAC ID: 0143263434
Enrollment ID: I20090209000547

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameWarren Scott Goldblatt
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1689677742
PECOS PAC ID: 3779796230
Enrollment ID: I20110516000880

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameLucian Szmyd
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1376548149
PECOS PAC ID: 6406925585
Enrollment ID: I20110624000302

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameAndre J Witkin
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1285811216
PECOS PAC ID: 3173656097
Enrollment ID: I20130111000347

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameTimothy Sullivan
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1538486717
PECOS PAC ID: 4789825167
Enrollment ID: I20140805000447

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameClaudia Bartolini
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1497071096
PECOS PAC ID: 5294959938
Enrollment ID: I20150824001899

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameRenee Theroux Lynch
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1083066005
PECOS PAC ID: 1951670561
Enrollment ID: I20170712003302

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameHilary Hamer
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1841720109
PECOS PAC ID: 1557632692
Enrollment ID: I20170808000504

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameKinley Beck
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1770840365
PECOS PAC ID: 8123318383
Enrollment ID: I20190628000762

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameDwight Brooks Arvidson
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1528125283
PECOS PAC ID: 0446650279
Enrollment ID: I20210615002401

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameJennifer Ling
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1366860025
PECOS PAC ID: 7618194051
Enrollment ID: I20220708003085

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Provider NameJason Thomas Szelog
Provider TypePractitioner - Ophthalmology
Provider IdentifiersNPI Number: 1366936882
PECOS PAC ID: 6800122235
Enrollment ID: I20230522000425

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Eyesight Ophthalmic Services Pllc is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Eyesight Ophthalmic Services Pllc
155 Borthwick Ave, Suite 200 East,
Portsmouth, NH 03801-7156

Ph: (603) 436-1773
Eyesight Ophthalmic Services Pllc
155 Borthwick Ave, Suite 200 East,
Portsmouth, NH 03801-7156

Ph: (603) 436-1773

News Archive

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.

Antiretroviral drugs may increase gay and bisexual men's susceptibility to syphilis

The antiretroviral drugs used to treat HIV infection might inadvertently be boosting gay/bisexual men's susceptibility to the bacteria responsible for syphilis, Treponema pallidum, conclude researchers in the journal Sexually Transmitted Infections.

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

U.N. asks for $447M in humanitarian aid for Yemen

The U.N. on Sunday released its Yemen Humanitarian Response Plan 2012, asking for $447 million in humanitarian assistance targeted toward four million vulnerable people in the country, Reuters reports (Fuchs, 12/18).

Internet-based support can help young people with mentally ill relatives

When someone is affected by mental illness, the people around him or her are forced to act both as supervisor and as support. Research at the Sahlgrenska Academy at the University of Gothenburg, Sweden, has shown that internet-based support can be a great help - and the site created during the research project is now being handed on to voluntary personnel.

Read more News

› Verified 4 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.